InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
T+90 hit rate
60%
T+90 mean return
+5.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by HAUGHEY THOMAS, Director. Officer active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 8 disclosures have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €1.5m. History available since 6 December 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
4,357 shares0Common StockSEC:0001272247-26-000004:0
2,000 sharesCommon StockSEC:0001272247-26-000004:1
19,341 shares@ US$85.9394.2% of flowCommon StockSEC:0001272247-25-000005:0
4,336 shares0Common StockSEC:0001272247-25-000003:0
4,410 shares0Common StockSEC:0001272247-24-000003:0
6,865 shares0Common StockSEC:0001104659-23-064140:0
10,049 shares0Common StockSEC:0001415889-22-004401:0
2,500 shares@ US$39.380.0049% mcap50.0% of flowCommon StockSEC:0001415889-21-005743:0
Canonical exit: 6 Mar 2022 (T+90)
8 of 8 declarations
About HAUGHEY THOMAS
Thomas Haughey serves as a Director at ANI Pharmaceuticals Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector allows him to provide informed perspectives on operations and growth initiatives.
